{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:52:51Z","timestamp":1769601171073,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaut.2024.103325","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T03:19:10Z","timestamp":1728962350000},"page":"103325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases"],"prefix":"10.1016","volume":"149","author":[{"given":"Tobias","family":"K\u00e4lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Passarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Filipowic-Sinnreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Semela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Sallusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Cerny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-5029","authenticated-orcid":false,"given":"Benedetta","family":"Terziroli Beretta-Piccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103325_bib1","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","author":"Baden","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103325_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103325_bib3","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41591-021-01583-4","article-title":"BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar","volume":"27","author":"Tang","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2024.103325_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2024.103325_bib5","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.jhep.2023.02.038","article-title":"The present evidence summary of SARS-CoV-2 vaccine-associated liver injury: a rapid systematic review","volume":"79","author":"Li","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2024.103325_bib6","doi-asserted-by":"crossref","unstructured":"C. Efe, A.V. Kulkarni, B.T. Beretta-Piccoli, B. Magro, A.F. St\u00e4ttermayer, M. Cengiz, D. Clayton-Chubb, C. Lammert, C. Bernsmeier, \u00d6. G\u00fcl, F.H. la Tijera, M. Anders, E. Lytvyak, M. Ak\u0131n, T. Purnak, R. Liberal, M. Peralta, B. Ebik, S. Duman, N. Demir, Y. Balaban, \u00c1. Urzua, F. Contreras, M.G. Venturelli, Y. Bilgi\u00e7, A. Medina, M. Girala, F. G\u00fcn\u015far, M.-C. Londo\u00f1o, T. Androutsakos, A. Kisch, A. Yurci, F. G\u00fczelbult, Y.F. \u00c7a\u011f\u0131n, E. Avc\u0131, M. Aky\u0131ld\u0131z, E.K. Dindar-Demiray, M. Harputluo\u011flu, R. Kumar, S.K. Satapathy, M. Mendizabal, M. Silva, S. Fagiuoli, S.K. Roberts, N.K. Soylu, R. Idilman, E.M. Yoshida, A.J. Montano-Loza, G.N. Dalekos, E. Ridruejo, T.D. Schiano, S. Wahlin, Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome, Hepatology n\/a (n.d.). https:\/\/doi.org\/10.1002\/hep.32572.","DOI":"10.1002\/hep.32572"},{"key":"10.1016\/j.jaut.2024.103325_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-Mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jaut.2024.103325_bib8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103325_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102706","article-title":"Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity?","author":"Ghielmetti","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103325_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102896","article-title":"COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman","volume":"132","author":"Ning","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103325_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/08916934.2023.2229072","article-title":"The onset of de novo autoantibodies in healthcare workers after mRNA based anti-SARS-CoV-2 vaccines: a single centre prospective follow-up study","volume":"56","author":"Sacchi","year":"2023","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2024.103325_bib12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41467-023-36686-8","article-title":"SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity","volume":"14","author":"Jaycox","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2024.103325_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"International autoimmune hepatitis group, overlap syndromes: the international autoimmune hepatitis group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2024.103325_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2024.103325_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"European Association for the Study of the Liver, EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2024.103325_bib16","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2024.103325_bib17","doi-asserted-by":"crossref","DOI":"10.57187\/smw.2023.40102","article-title":"Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study","volume":"153","author":"Ludz","year":"2023","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.jaut.2024.103325_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102578","article-title":"Primary biliary cholangitis with normal alkaline phosphatase: a neglected clinical entity challenging current guidelines","volume":"116","author":"Terziroli Beretta-Piccoli","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103325_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12026-021-09233-0","article-title":"How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative","volume":"69","author":"von M\u00fchlen","year":"2021","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2024.103325_bib20","article-title":"Serology in autoimmune hepatitis: a clinical-practice approach","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103325_bib21","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200163","article-title":"mRNA COVID-19 vaccination does not exacerbate symptoms or trigger neural antibody responses in multiple sclerosis","volume":"10","author":"Blanco","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jaut.2024.103325_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/rheumatology\/keac322","article-title":"Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis","volume":"62","author":"Blank","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103325_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/vaccines11020476","volume":"11","author":"Gazitt","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jaut.2024.103325_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s12026-022-09309-5","article-title":"The effect of the BNT162b2 vaccine on antinuclear antibody and antiphospholipid antibody levels","volume":"70","author":"Noureldine","year":"2022","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2024.103325_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00760-5","article-title":"The advances of adjuvants in mRNA vaccines","volume":"8","author":"Xie","year":"2023","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jaut.2024.103325_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/ijph.2023.1605852","article-title":"Factors associated with COVID-19 non-vaccination in Switzerland: a nationwide study","volume":"68","author":"Sabatini","year":"2023","journal-title":"Int J Public Health"},{"key":"10.1016\/j.jaut.2024.103325_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2024.103325_bib28","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","article-title":"New-onset IgG autoantibodies in hospitalized patients with COVID-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T11:41:09Z","timestamp":1738496469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124001598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"alternative-id":["S0896841124001598"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103325","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103325"}}